tiprankstipranks
Trending News
More News >
Editas Medicine Inc (EDIT)
NASDAQ:EDIT

Editas Medicine (EDIT) Similar Stocks

Compare
3,547 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Editas Medicine
$2.44
$236.24M
22.61%
4 Buy
4 Hold
0 Sell
Moderate Buy
Cellectis SA
$3.90
$341.08M
136.60%
1 Buy
2 Hold
0 Sell
Moderate Buy
Foghorn Therapeutics
$4.37
$199.55M
-2.85
-29.37%
7 Buy
0 Hold
0 Sell
Strong Buy
Elicio Therapeutics
$8.09
$149.50M
-2.19
44.72%
2 Buy
0 Hold
0 Sell
Moderate Buy
Vor Biopharma
$10.72
$183.17M
-48.46%
4 Buy
1 Hold
0 Sell
Strong Buy
Caribou Biosciences
$1.87
$202.08M
-1.22
-7.88%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EDIT
Editas Medicine
2.44
0.55
29.10%
CLLS
Cellectis SA
4.59
2.74
148.11%
FHTX
Foghorn Therapeutics
4.45
-1.33
-23.01%
ELTX
Elicio Therapeutics
8.09
3.10
62.12%
VOR
Vor Biopharma
10.72
-8.84
-45.19%
CRBU
Caribou Biosciences
1.87
-0.07
-3.61%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts